Neuropace Inc (NPCE)

$16.97 +0.31 (1.86%)
Market Cap 533.59M
Revenue (ttm) 79.91M
Net Income (ttm) -27.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -33.96%
Debt to Equity Ratio 3.17
Volume 223,100
Avg Vol 206,644
Day's Range N/A - N/A
Shares Out 33.31M
Stochastic %K 97%
Beta 1.85
Analysts Strong Sell
Price Target $17.50

Company Profile

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data m...

Industry: Medical Devices
Sector: Healthcare
Phone: 650 237 2700
Fax: 650 237 2701
Address:
455 North Bernardo Avenue, Mountain View, United States
stockwitsuser2449
stockwitsuser2449 Dec. 1 at 12:35 PM
$NPCE
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 20 at 7:07 PM
$NPCE large drop here
1 · Reply
HypnoTrader
HypnoTrader Nov. 19 at 6:48 PM
$NPCE no way to confirm anything an anonymous account is telling you, but the chart seems to agree....
1 · Reply
HypnoTrader
HypnoTrader Nov. 19 at 6:46 PM
$NPCE
0 · Reply
johnemac
johnemac Nov. 19 at 6:45 PM
$NPCE In a sample size of one my son continues to be seizure-free since February and his RNS (NPCE's main product) surgery. In addition he is able now to wean back his meds considerably. Thank you Neuropace.
0 · Reply
Scoops1212
Scoops1212 Nov. 19 at 3:01 PM
$NPCE If you believe in the treatment, this is the time to go big. The numbers show this should be at $40, and is at $13. I’m not a pumper, and know how to crunch these numbers. This should be at $40 right now!
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 10:54 AM
$NOG $NPCE $NRDS $NRT $NTCT
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 15 at 6:01 PM
$NPCE 15 strike put options working out so far
0 · Reply
Scoops1212
Scoops1212 Nov. 12 at 2:05 PM
$NPCE The big question is what does this company have to do financially, to beat their opening price over 4 years ago? They’ve had strong quarterly’s all but once, and they had never reached $20. What da?!
0 · Reply
Joby099
Joby099 Nov. 7 at 2:03 PM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
Latest News on NPCE
NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting

Dec 2, 2025, 8:01 AM EST - 3 days ago

NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting

NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services

Nov 24, 2025, 8:00 AM EST - 11 days ago

NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services

NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 11:06 PM EST - 4 weeks ago

NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call Transcript

NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Nov 4, 2025, 4:05 PM EST - 4 weeks ago

NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025

Oct 22, 2025, 8:00 AM EDT - 6 weeks ago

NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025

NeuroPace to Participate in Upcoming Healthcare Conferences

Aug 28, 2025, 8:00 AM EDT - 3 months ago

NeuroPace to Participate in Upcoming Healthcare Conferences

NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 9:50 PM EDT - 4 months ago

NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript

NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Aug 12, 2025, 4:05 PM EDT - 4 months ago

NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases

Aug 1, 2025, 7:30 AM EDT - 4 months ago

NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases

NeuroPace Announces Strategic CFO Transition

Jun 24, 2025, 4:05 PM EDT - 5 months ago

NeuroPace Announces Strategic CFO Transition

NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm

Jun 24, 2025, 3:42 AM EDT - 5 months ago

NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Shareholders to Connect

Jun 13, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Shareholders to Reach Out

Jun 12, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Shareholders to Learn More About the Investigation

Jun 11, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Shareholders to Learn More About the Investigation

NeuroPace, Inc. (NPCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 10, 2025, 10:00 AM EDT - 6 months ago

NeuroPace, Inc. (NPCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NeuroPace, Inc. (NPCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jun 9, 2025, 10:00 AM EDT - 6 months ago

NeuroPace, Inc. (NPCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Investors to Connect

Jun 8, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages NeuroPace, Inc. (NPCE) Stockholders to Inquire about Securities Investigation

Jun 6, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages NeuroPace, Inc. (NPCE) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Investors to Learn More About the Investigation

Jun 5, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Investors to Learn More About the Investigation

NeuroPace Secures Up to $75 Million in Debt Financing

Jun 4, 2025, 4:09 PM EDT - 6 months ago

NeuroPace Secures Up to $75 Million in Debt Financing

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Stockholders to Reach Out

Jun 3, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Stockholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Stockholders to Connect

Jun 2, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Stockholders to Connect

NeuroPace, Inc. (NPCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 6 months ago

NeuroPace, Inc. (NPCE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Stockholders to Learn More About the Investigation

May 30, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages NeuroPace, Inc. (NPCE) Investors to Inquire about Securities Investigation

May 29, 2025, 12:45 PM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages NeuroPace, Inc. (NPCE) Investors to Inquire about Securities Investigation

Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?

May 27, 2025, 12:48 PM EDT - 6 months ago

Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

May 27, 2025, 8:00 AM EDT - 6 months ago

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:33 PM EDT - 7 months ago

NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript

NeuroPace Reports First Quarter 2025 Financial Results

May 13, 2025, 4:05 PM EDT - 7 months ago

NeuroPace Reports First Quarter 2025 Financial Results

NeuroPace Provides Update on Tariff Status

Apr 14, 2025, 4:05 PM EDT - 8 months ago

NeuroPace Provides Update on Tariff Status

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

Apr 8, 2025, 8:00 AM EDT - 8 months ago

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

Apr 3, 2025, 8:00 AM EDT - 8 months ago

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

NeuroPace Announces Refocusing of Product Portfolio

Apr 2, 2025, 4:05 PM EDT - 8 months ago

NeuroPace Announces Refocusing of Product Portfolio

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 26, 2025, 8:00 AM EDT - 9 months ago

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 7:45 PM EST - 9 months ago

NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 4, 2025, 4:05 PM EST - 9 months ago

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

Mar 3, 2025, 9:15 PM EST - 9 months ago

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

Mar 3, 2025, 4:05 PM EST - 9 months ago

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

stockwitsuser2449
stockwitsuser2449 Dec. 1 at 12:35 PM
$NPCE
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 20 at 7:07 PM
$NPCE large drop here
1 · Reply
HypnoTrader
HypnoTrader Nov. 19 at 6:48 PM
$NPCE no way to confirm anything an anonymous account is telling you, but the chart seems to agree....
1 · Reply
HypnoTrader
HypnoTrader Nov. 19 at 6:46 PM
$NPCE
0 · Reply
johnemac
johnemac Nov. 19 at 6:45 PM
$NPCE In a sample size of one my son continues to be seizure-free since February and his RNS (NPCE's main product) surgery. In addition he is able now to wean back his meds considerably. Thank you Neuropace.
0 · Reply
Scoops1212
Scoops1212 Nov. 19 at 3:01 PM
$NPCE If you believe in the treatment, this is the time to go big. The numbers show this should be at $40, and is at $13. I’m not a pumper, and know how to crunch these numbers. This should be at $40 right now!
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 10:54 AM
$NOG $NPCE $NRDS $NRT $NTCT
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 15 at 6:01 PM
$NPCE 15 strike put options working out so far
0 · Reply
Scoops1212
Scoops1212 Nov. 12 at 2:05 PM
$NPCE The big question is what does this company have to do financially, to beat their opening price over 4 years ago? They’ve had strong quarterly’s all but once, and they had never reached $20. What da?!
0 · Reply
Joby099
Joby099 Nov. 7 at 2:03 PM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 7 at 12:29 PM
$QURE $BIOA $DYN and $NPCE now. glta
0 · Reply
Joby099
Joby099 Nov. 7 at 2:21 AM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
Joby099
Joby099 Nov. 6 at 8:37 PM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
Scoops1212
Scoops1212 Nov. 6 at 5:07 PM
$NPCE It would have been very nice to see another big push this morning at the price we opened at.
0 · Reply
Joby099
Joby099 Nov. 6 at 1:18 PM
$PLRZ $RIGL $NPCE $LITE
0 · Reply
topstockalerts
topstockalerts Nov. 5 at 9:46 PM
Top Gainers PT2 $SONN $LNAI $SORA $NPCE $LMND
0 · Reply
topstockalerts
topstockalerts Nov. 5 at 8:58 PM
Top Gainers PT2 $SMX $SORA $NPCE $BW $LMND
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:37 PM
JP Morgan has updated their rating for NeuroPace ( $NPCE ) to Overweight with a price target of 18.
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 5 at 7:31 PM
$NPCE giving up on those earlier gains at the moment, no volume
0 · Reply
stockwitsuser2449
stockwitsuser2449 Nov. 5 at 6:32 PM
$NPCE nice runs. those puts are cheap to :)
0 · Reply
topstockalerts
topstockalerts Nov. 5 at 4:01 PM
$NPCE It wants to move higher..
0 · Reply
IsabellaDC
IsabellaDC Nov. 5 at 3:48 PM
Movers over a dollar: $SLDP $SORA $EVC $APPS $NPCE and so on.
0 · Reply